RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: nose disease
Accession: DOID:2825
browse the term
Definition: Disorders of the nose, general or unspecified.
Synonyms: exact_synonym: Nasal Diseases; Nasal Disorder; disorder of the nose; nasal disease; nasal disorders; nose diseases
primary_id: MESH:D009668
For additional species annotation, visit the
Alliance of Genome Resources .
GViewer not supported for the selected species.
G
Abcb1
ATP binding cassette subfamily B member 1
severity
ISO
DNA:snp:exon:c.1236C>T (human)
RGD
PMID:24040855
RGD:8657076
NCBI chrNW_004936763:1,225,355...1,308,257
Ensembl chrNW_004936763:1,226,482...1,297,427
G
Bcl2
BCL2 apoptosis regulator
ISO
mRNA, protein:increased expression:nasal mucosa (rat)
RGD
PMID:15362690
RGD:11522724
NCBI chrNW_004936497:2,209,136...2,373,580
Ensembl chrNW_004936497:2,210,334...2,210,921
G
Cat
catalase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29028686
NCBI chrNW_004936533:3,601,270...3,637,128
Ensembl chrNW_004936533:3,600,955...3,637,422
G
Ccl26
C-C motif chemokine ligand 26
ISO
protein:increased expression:oronasal secretion (human)
RGD
PMID:23883806
RGD:7364793
NCBI chrNW_004936543:2,414,948...2,416,922
Ensembl chrNW_004936543:2,414,850...2,416,953
G
Cd40
CD40 molecule
ISO
protein:increased expression:lymphocyte
RGD
PMID:19086656
RGD:8547782
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
G
Cd40lg
CD40 ligand
ISO
protein:increased expression:lymphocyte
RGD
PMID:19086656
RGD:8547782
NCBI chrNW_004936513:10,607,617...10,620,403
Ensembl chrNW_004936513:10,607,617...10,620,403
G
Cldn3
claudin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33441633
NCBI chrNW_004936543:2,952,054...2,953,313
Ensembl chrNW_004936543:2,951,086...2,953,956
G
Cldn7
claudin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33441633
NCBI chrNW_004936595:550,359...552,214
Ensembl chrNW_004936595:550,568...552,632
G
Ctla4
cytotoxic T-lymphocyte associated protein 4
treatment
ISO
RGD
PMID:10436391
RGD:11344920
NCBI chrNW_004936631:484,356...489,643
Ensembl chrNW_004936631:484,356...489,643
G
F2
coagulation factor II, thrombin
ISO
protein:increased expression:nasal mucus
RGD
PMID:21711961
RGD:5147783
NCBI chrNW_004936562:2,371,725...2,388,617
Ensembl chrNW_004936562:2,372,044...2,388,650
G
Gria1
glutamate ionotropic receptor AMPA type subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624383
NCBI chrNW_004936515:8,937,391...9,236,438
Ensembl chrNW_004936515:8,940,009...9,083,151
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34624383
NCBI chrNW_004936576:3,800,369...3,940,324
Ensembl chrNW_004936576:3,800,075...3,941,003
G
Hrh1
histamine receptor H1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23333628
NCBI chrNW_004936602:2,182,053...2,185,297
Ensembl chrNW_004936602:2,183,831...2,185,297
G
Ifng
interferon gamma
treatment
ISO
associated with Asthma
RGD
PMID:12787306 PMID:18510219
RGD:10755770 RGD:7829803
NCBI chrNW_004936545:6,139,130...6,144,543
Ensembl chrNW_004936545:6,139,116...6,148,452
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:23253209 PMID:23883806
RGD:7364793 RGD:7364818
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
G
Il13
interleukin 13
susceptibility no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:SNPs:promoter, cds:-1112C>T, p.R130Q (rs1800925, rs20541) (human)
OMIM CTD RGD
PMID:12928861
RGD:8549516
NCBI chrNW_004936647:2,529,933...2,532,503
Ensembl chrNW_004936647:2,530,491...2,532,373
G
Il13ra2
interleukin 13 receptor subunit alpha 2
ISO
protein:increased expression:serum
RGD
PMID:21462799
RGD:8549521
NCBI chrNW_004936499:860,179...883,884
Ensembl chrNW_004936499:863,599...883,855
G
Il17a
interleukin 17A
susceptibility
ISO
DNA:snp:promoter:c.-444A>G (human) mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:21535180 PMID:22507625
RGD:5147409 RGD:9068429
NCBI chrNW_004936476:8,621,860...8,625,008
Ensembl chrNW_004936476:8,621,860...8,625,008
G
Il18
interleukin 18
no_association severity
ISO
DNA:SNP:promoter:-140C>G (rs360721) (human) DNA:SNP:promoter:-137G>C (rs187238) (human)
RGD
PMID:22840759
RGD:8655914
NCBI chrNW_004936612:2,306,963...2,325,086
Ensembl chrNW_004936612:2,306,875...2,325,189
G
Il1b
interleukin 1 beta
ISO
protein:increased expression:nasal mucus
RGD
PMID:7750009
RGD:7401199
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
G
Il2
interleukin 2
ISO
RGD
PMID:12592663
RGD:8662963
NCBI chrNW_004936662:1,594,953...1,599,625
Ensembl chrNW_004936662:1,594,953...1,599,625
G
Il5
interleukin 5
treatment
ISO
RGD
PMID:23934070 PMID:24620662
RGD:11354976 RGD:11522769
NCBI chrNW_004936647:2,647,982...2,651,477
Ensembl chrNW_004936647:2,648,241...2,651,430
G
Itgb2
integrin subunit beta 2
treatment
ISO
RGD
PMID:12046991
RGD:9698435
NCBI chrNW_004936778:1,286,475...1,311,184
Ensembl chrNW_004936778:1,286,341...1,311,194
G
LOC101955076
low affinity immunoglobulin gamma Fc region receptor III-A
susceptibility
ISO
DNA:polymorphism:exon:p.F158V(rs396991)(human)
RGD
PMID:18199088
RGD:5508449
NCBI chrNW_004937131:42,523...49,533
G
LOC101968920
eotaxin
treatment
ISO
RGD
PMID:23089405
RGD:7248414
NCBI chrNW_004936538:835,436...848,907
Ensembl chrNW_004936538:835,859...837,710 Ensembl chrNW_004936538:835,859...837,710
G
LOC101968921
angiotensin-converting enzyme
no_association
ISO
DNA:deletion:intron:IVS16+1464-1751del (human)
RGD
PMID:15112973
RGD:8142345
NCBI chrNW_004936541:4,157,847...4,178,156
Ensembl chrNW_004936541:4,157,393...4,178,177
G
Muc1
mucin 1, cell surface associated
severity
ISO
mRNA,protein:decreased expression:nasal mucosa
RGD
PMID:31425778
RGD:127345100
NCBI chrNW_004936580:4,691,870...4,694,092
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
ISO
mRNA, protein:increased expression:nasal cavity epithelium
RGD
PMID:22972875
RGD:7364746
NCBI chrNW_004936816:129,926...159,396
G
Nod2
nucleotide binding oligomerization domain containing 2
ISO
mRNA:increased expression:nasal mucosa (human)
RGD
PMID:23858718
RGD:8547523
NCBI chrNW_004936475:3,708,069...3,742,845
Ensembl chrNW_004936475:3,713,362...3,745,982
G
Ocln
occludin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33441633
NCBI chrNW_004936480:99,516...152,834
Ensembl chrNW_004936480:98,371...152,413
G
Pon1
paraoxonase 1
severity
ISO
protein:decreased activity:plasma (human)
RGD
PMID:23406590
RGD:8547583
NCBI chrNW_004936585:4,954,871...4,979,560
Ensembl chrNW_004936585:4,954,869...4,979,591
G
Prkg1
protein kinase cGMP-dependent 1
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:24012634
RGD:7775060
NCBI chrNW_004936787:330,390...1,491,994
Ensembl chrNW_004936787:332,342...1,491,285
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16979129
NCBI chrNW_004936481:3,821,564...3,828,086
G
Scgb1a1
secretoglobin family 1A member 1
ISO
mRNA:decreased expression:nasal mucosa, lung
RGD
PMID:17882576
RGD:5144135
NCBI chrNW_004936581:798,738...801,614
Ensembl chrNW_004936581:798,739...801,633
G
Scgb3a2
secretoglobin family 3A member 2
susceptibility
ISO
DNA:SNP: :rs7726552 (human)
RGD
PMID:21410962
RGD:5144225
NCBI chrNW_004936504:6,933,641...6,936,838
Ensembl chrNW_004936504:6,933,769...6,936,838
G
Serpine1
serpin family E member 1
ISO
mRNA:increased expression:nasal mucosa (mouse)
RGD
PMID:21339035
RGD:8547809
NCBI chrNW_004936543:1,032,543...1,040,956
Ensembl chrNW_004936543:1,032,794...1,039,123
G
Tacr1
tachykinin receptor 1
ISO
mRNA:increased expression:nasal mucosa
RGD
PMID:12768696
RGD:5147835
NCBI chrNW_004936556:1,266,621...1,421,271
Ensembl chrNW_004936556:1,266,613...1,421,275
G
Tgfb1
transforming growth factor beta 1
treatment
ISO
RGD
PMID:31368266
RGD:14995445
NCBI chrNW_004936661:3,742,080...3,758,266
Ensembl chrNW_004936661:3,742,066...3,758,272
G
Tlr2
toll like receptor 2
severity
ISO
mRNA:decreased expression:nasal mucosa: protein:increased expression:neutrophil: DNA:polymorphism:cds:p.R753Q(human)
RGD
PMID:18219831 PMID:18381801 PMID:22402138 PMID:22555057
RGD:7800732 RGD:7800742 RGD:8552972 RGD:8552993
NCBI chrNW_004936576:522,234...531,660
Ensembl chrNW_004936576:527,434...529,788
G
Tlr4
toll like receptor 4
severity susceptibility treatment no_association
ISO
protein:increased expression:nasal lavage,leukocyte, bone marrow: DNA:polymorphism:cds:p.D299G(human) DNA:SNP: :rs1927911(human) DNA:polymorphism: :4216G>C(human) protein:decreased expression:nasal mucosa:
RGD
PMID:17069098 PMID:19763595 PMID:22402138 PMID:22555057 PMID:22577387 PMID:23639307 More...
RGD:4145354 RGD:7800732 RGD:7800736 RGD:7800738 RGD:7800740 RGD:8552993
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
G
Il3
interleukin 3
susceptibility
ISO
DNA:SNP: :rs40401(human)
RGD
PMID:23953855
RGD:13506915
NCBI chrNW_004936647:3,102,922...3,104,758
G
Smchd1
structural maintenance of chromosomes flexible hinge domain containing 1
ISO
ClinVar Annotator: match by term: Arhinia, choanal atresia, and microphthalmia
OMIM ClinVar
PMID:672092 PMID:5032329 PMID:6802865 PMID:8446727 PMID:8723126 PMID:11321738 PMID:16353241 PMID:23143600 PMID:23432817 PMID:23852095 PMID:25741868 PMID:26440771 PMID:26467025 PMID:26842768 PMID:28067909 PMID:28067911 PMID:28492532 PMID:31243061 PMID:31312724 More...
NCBI chrNW_004936672:1,686,070...1,838,315
Ensembl chrNW_004936672:1,685,734...1,838,315
G
LOC101969065
mamu class II histocompatibility antigen, DR alpha chain
susceptibility
ISO
DNA:SNPs,haplotype:introns:
RGD
PMID:22391069
RGD:13506908
NCBI chrNW_004936727:540,225...544,968
Ensembl chrNW_004936727:540,217...545,036
G
Tbx21
T-box transcription factor 21
ISO
ClinVar Annotator: match by term: Asthma and nasal polyps
ClinVar
PMID:15806396
NCBI chrNW_004936490:13,546,405...13,558,635
Ensembl chrNW_004936490:13,546,292...13,558,635
G
Alox15
arachidonate 15-lipoxygenase
ISO
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance
ClinVar
PMID:17959182 PMID:21558275 PMID:30643255
NCBI chrNW_004936677:3,232,183...3,241,307
Ensembl chrNW_004936677:3,232,183...3,241,253
G
Ptger2
prostaglandin E receptor 2
ISO
OMIM
NCBI chrNW_004936697:2,440,943...2,453,897
Ensembl chrNW_004936697:2,440,901...2,453,975
G
Tbx21
T-box transcription factor 21
ISO
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance
OMIM ClinVar
PMID:25741868
NCBI chrNW_004936490:13,546,405...13,558,635
Ensembl chrNW_004936490:13,546,292...13,558,635
G
Frem1
FRAS1 related extracellular matrix 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23221805
NCBI chrNW_004936539:8,338,624...8,508,031
Ensembl chrNW_004936539:8,351,159...8,508,069
G
Adnp2
ADNP homeobox 2
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chrNW_004936616:124,590...145,944
Ensembl chrNW_004936616:123,758...146,254
G
Atp9b
ATPase phospholipid transporting 9B (putative)
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chrNW_004936616:604,132...846,645
Ensembl chrNW_004936616:603,588...846,640
G
Ctdp1
CTD phosphatase subunit 1
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chrNW_004936616:369,306...407,083
Ensembl chrNW_004936616:369,893...407,093
G
Galr1
galanin receptor 1
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chrNW_004936616:2,007,339...2,020,737
Ensembl chrNW_004936616:2,007,352...2,020,737
G
Hsbp1l1
heat shock factor binding protein 1 like 1
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chrNW_004936616:244,940...249,941
Ensembl chrNW_004936616:244,940...248,499
G
Kcng2
potassium voltage-gated channel modifier subfamily G member 2
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chrNW_004936616:294,466...338,332
Ensembl chrNW_004936616:293,314...310,684
G
Mbp
myelin basic protein
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chrNW_004936616:2,082,154...2,159,028
Ensembl chrNW_004936616:2,082,099...2,159,070
G
Nfatc1
nuclear factor of activated T cells 1
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chrNW_004936616:484,062...584,950
Ensembl chrNW_004936616:484,045...587,891
G
Pard6g
par-6 family cell polarity regulator gamma
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chrNW_004936616:50,504...115,679
Ensembl chrNW_004936616:50,498...115,613
G
Rbfa
ribosome binding factor A
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chrNW_004936616:185,616...201,405
Ensembl chrNW_004936616:192,886...201,411
G
Sall3
spalt like transcription factor 3
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chrNW_004936616:903,220...922,635
Ensembl chrNW_004936616:901,076...922,641
G
Slc66a2
solute carrier family 66 member 2
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chrNW_004936616:265,609...292,430
Ensembl chrNW_004936616:265,850...292,586
G
Txnl4a
thioredoxin like 4A
ISO
ClinVar Annotator: match by term: Bilateral choanal atresia, cardiac defects, deafness, and dysmorphic appearance | ClinVar Annotator: match by term: Burn-McKeown syndrome
OMIM ClinVar
PMID:1342861 PMID:14564154 PMID:16523509 PMID:25434003 PMID:25741868 PMID:28492532 PMID:34713892 More...
NCBI chrNW_004936616:220,255...232,042
Ensembl chrNW_004936616:220,274...234,870
G
Znf236
zinc finger protein 236
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chrNW_004936616:2,163,000...2,251,306
Ensembl chrNW_004936616:2,163,063...2,243,069
G
Znf516
zinc finger protein 516
ISO
ClinVar Annotator: match by term: Burn-McKeown syndrome
ClinVar
PMID:25434003
NCBI chrNW_004936616:2,451,952...2,553,843
Ensembl chrNW_004936616:2,452,248...2,553,693
G
Kmt2d
lysine methyltransferase 2D
ISO
ClinVar Annotator: match by term: Choanal atresia
ClinVar
PMID:25741868 PMID:31395954
NCBI chrNW_004936512:6,819,240...6,860,852
Ensembl chrNW_004936512:6,822,057...6,854,451
G
Ptpn14
protein tyrosine phosphatase non-receptor type 14
ISO
ClinVar Annotator: match by term: Choanal atresia and lymphedema
OMIM ClinVar
PMID:20826270 PMID:25741868
NCBI chrNW_004936628:3,739,223...3,916,157
Ensembl chrNW_004936628:3,739,152...3,907,662
G
Edn1
endothelin 1
ISO
protein:increased expression:inferior turbinate, nasal gland, inflammatory cell (human)
RGD
PMID:8845175
RGD:8661738
NCBI chrNW_004936534:885,489...892,292
Ensembl chrNW_004936534:885,287...891,772
G
Cd8a
CD8 subunit alpha
ameliorates
ISO
protein:decreased expression:blood, T cell (human)
RGD
PMID:24639246
RGD:124715444
NCBI chrNW_004936712:885,301...891,247
Ensembl chrNW_004936712:885,458...890,852
G
Il17a
interleukin 17A
ISO
protein:increased expression:uncinate process, nasal mucosa (human)
RGD
PMID:23613503
RGD:8696039
NCBI chrNW_004936476:8,621,860...8,625,008
Ensembl chrNW_004936476:8,621,860...8,625,008
G
Il1rn
interleukin 1 receptor antagonist
susceptibility
ISO
DNA:repeats:intron:IVS2+914_1000dup I/II alleles (human)
RGD
PMID:16549749
RGD:8549791
NCBI chrNW_004936783:1,447,158...1,466,331
Ensembl chrNW_004936783:1,447,106...1,466,340
G
Prg2
proteoglycan 2, pro eosinophil major basic protein
disease_progression
ISO
associated with Nasal Polyps;
RGD
PMID:24450586
RGD:13506943
NCBI chrNW_004936581:5,101,041...5,103,175
Ensembl chrNW_004936581:5,100,623...5,102,857
G
Acvrl1
activin A receptor like type 1
ISO
ClinVar Annotator: match by term: Epistaxis
ClinVar
PMID:11484689 PMID:15687131 PMID:16540754 PMID:17786384 PMID:18159113 PMID:18498373 PMID:20056902 PMID:20501893 PMID:21378382 PMID:22632830 PMID:23124896 PMID:23298310 PMID:23919827 PMID:25741868 PMID:26387786 PMID:27316748 PMID:28492532 PMID:30260738 PMID:32581362 More...
NCBI chrNW_004936512:9,364,551...9,379,131
Ensembl chrNW_004936512:9,364,149...9,379,431
G
Eng
endoglin
ISO
ClinVar Annotator: match by term: Spontaneous, recurrent epistaxis
ClinVar
PMID:15879500 PMID:16542389 PMID:28492532 PMID:30251589
NCBI chrNW_004936487:15,467,165...15,499,180
Ensembl chrNW_004936487:15,467,835...15,477,488
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
ISO
RGD
PMID:15040115
RGD:8662355
NCBI chrNW_004936476:22,717,308...22,725,127
Ensembl chrNW_004936476:22,717,260...22,725,182
G
Clu
clusterin
ISO
RGD
PMID:19903339
RGD:9014708
NCBI chrNW_004936675:499,745...513,515
Ensembl chrNW_004936675:499,199...513,836
G
Sox2
SRY-box transcription factor 2
ISO
DNA:amplification
RGD
PMID:23544055
RGD:8661654
NCBI chrNW_004936566:1,630,698...1,632,607
Ensembl chrNW_004936566:1,631,822...1,632,613
G
Tp53
tumor protein p53
ISO
RGD
PMID:19950227
RGD:8547762
NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425
G
Npy
neuropeptide Y
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:9288221
NCBI chrNW_004936478:1,289,437...1,296,819
Ensembl chrNW_004936478:1,290,505...1,296,874
G
Abcb1
ATP binding cassette subfamily B member 1
ISO
associated with Chronic Rhinosinusitis;protein:increased expression:nasal sinus (human)
RGD
PMID:22223515
RGD:8657074
NCBI chrNW_004936763:1,225,355...1,308,257
Ensembl chrNW_004936763:1,226,482...1,297,427
G
Adrb2
adrenoceptor beta 2
susceptibility
ISO
DNA:polymorphism:p.R16G(human)
RGD
PMID:17621827
RGD:8548469
NCBI chrNW_004936504:5,985,407...5,987,453
Ensembl chrNW_004936504:5,985,960...5,987,210
G
Alox15
arachidonate 15-lipoxygenase
ISO
mRNA:increased expression:nasal cavity epithelium CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20554417 PMID:30643255
RGD:5509597
NCBI chrNW_004936677:3,232,183...3,241,307
Ensembl chrNW_004936677:3,232,183...3,241,253
G
Ang
angiogenin
ISO
RGD
PMID:21711968
RGD:6892710
NCBI chrNW_004936880:39,372...40,070
G
Anxa1
annexin A1
ISO
RGD
PMID:20549082
RGD:7421567
NCBI chrNW_004936503:9,124,314...9,142,372
Ensembl chrNW_004936503:9,124,264...9,142,413
G
Bdnf
brain derived neurotrophic factor
ISO
associated with Sinusitis;protein:decreased expression:respiratory system mucosa
RGD
PMID:19958603
RGD:4891064
NCBI chrNW_004936540:5,530,081...5,582,765
Ensembl chrNW_004936540:5,529,942...5,585,014
G
Cat
catalase
ISO
protein:increased activity:nasal concha:
RGD
PMID:16287205
RGD:9479048
NCBI chrNW_004936533:3,601,270...3,637,128
Ensembl chrNW_004936533:3,600,955...3,637,422
G
Ccl1
C-C motif chemokine ligand 1
ISO
associated with Sinusitis
RGD
PMID:20598643
RGD:4891418
NCBI chrNW_004936538:781,687...784,199
Ensembl chrNW_004936538:781,687...784,199
G
Ccl20
C-C motif chemokine ligand 20
ISO
associated with Rhinosinusitis associated with Allergic Rhinitis
RGD
PMID:19027509 PMID:22287435
RGD:7483586 RGD:7483612
NCBI chrNW_004936525:8,238,128...8,240,974
Ensembl chrNW_004936525:8,237,831...8,240,974
G
Ccl24
C-C motif chemokine ligand 24
ISO
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:10415058
RGD:4145448
NCBI chrNW_004936543:2,400,743...2,403,558
Ensembl chrNW_004936543:2,400,768...2,403,217
G
Ccl26
C-C motif chemokine ligand 26
ISO
associated with Sinusitis;mRNA:increased expression:nasal cavity epithelium
RGD
PMID:21303604
RGD:5130929
NCBI chrNW_004936543:2,414,948...2,416,922
Ensembl chrNW_004936543:2,414,850...2,416,953
G
Ccr6
C-C motif chemokine receptor 6
ISO
associated with Rhinosinusitis
RGD
PMID:22287435
RGD:7483612
NCBI chrNW_004936489:16,669,297...16,689,451
Ensembl chrNW_004936489:16,669,297...16,689,451
G
Chia
chitinase acidic
ISO
associated with Sinusitis; mRNA:increased expression:mucosa of ethmoidal sinus (human)
RGD
PMID:16871939
RGD:5024927
NCBI chrNW_004939091:1,194...12,273
Ensembl chrNW_004939091:1,190...12,272
G
Cysltr1
cysteinyl leukotriene receptor 1
ISO
protein:increased expression:nasal cavity epithelium associated with Asthma associated with Rhinitis;mRNA:increased expression:nasal cavity epithelium
RGD
PMID:11591188 PMID:16689996 PMID:16739673
RGD:4783198 RGD:4848936 RGD:4889117
NCBI chrNW_004936547:479,261...504,757
G
Egr1
early growth response 1
ISO
mRNA:increased expression:nasal polyp (human)
RGD
PMID:19158123
RGD:4890001
NCBI chrNW_004936531:7,625,956...7,629,041
Ensembl chrNW_004936531:7,625,892...7,629,749
G
Fas
Fas cell surface death receptor
ISO
protein:decreased expression:nasal polyp (human)
RGD
PMID:15283292
RGD:8662435
NCBI chrNW_004936735:209,369...234,582
G
Fgf1
fibroblast growth factor 1
ISO
RGD
PMID:16720444
RGD:8655569
NCBI chrNW_004936504:11,590,687...11,684,410
Ensembl chrNW_004936504:11,590,637...11,685,194
G
Hgf
hepatocyte growth factor
ISO
mRNA,protein:increased expression:nasal cavity mucosa:
RGD
PMID:16982975
RGD:8548613
NCBI chrNW_004936734:354,798...428,356
Ensembl chrNW_004936734:356,115...428,779
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:11593541
RGD:8547687
NCBI chrNW_004936659:616,570...627,172
Ensembl chrNW_004936659:616,752...627,174
G
Ifng
interferon gamma
ISO
protein:increased expression:nasal mucosa, tissue:
RGD
PMID:9149164
RGD:8158035
NCBI chrNW_004936545:6,139,130...6,144,543
Ensembl chrNW_004936545:6,139,116...6,148,452
G
Igf1
insulin like growth factor 1
ISO
mRNA:increased expression:nasal cavity mucosa:
RGD
PMID:18202785
RGD:8548875
NCBI chrNW_004936492:11,709,623...11,784,028
Ensembl chrNW_004936492:11,709,222...11,778,351
G
Il10
interleukin 10
ISO
RGD
PMID:22462754
RGD:7364835
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
G
Il13
interleukin 13
ISO
associated with Rhinosinusitis;protein:increased expression:serum
RGD
PMID:23969075
RGD:8549540
NCBI chrNW_004936647:2,529,933...2,532,503
Ensembl chrNW_004936647:2,530,491...2,532,373
G
Il16
interleukin 16
ISO
associated with Sinusitis
RGD
PMID:17431659
RGD:5024933
NCBI chrNW_004936483:19,417,580...19,512,654
Ensembl chrNW_004936483:19,418,086...19,512,639
G
Il17a
interleukin 17A
ISO
associated with rhinitis; protein:increased expression:nasal mucosa protein:increased expression:nose, serum
RGD
PMID:20506642 PMID:21091665
RGD:4889132 RGD:4889137
NCBI chrNW_004936476:8,621,860...8,625,008
Ensembl chrNW_004936476:8,621,860...8,625,008
G
Il1a
interleukin 1 alpha
susceptibility
ISO
associated with asthma; DNA:polymorphism:exon: DNA:SNPs:exon:
RGD
PMID:12752325 PMID:17638785
RGD:4142804 RGD:4142855
NCBI chrNW_004936783:1,210,715...1,218,315
Ensembl chrNW_004936783:1,210,809...1,218,315
G
Il5ra
interleukin 5 receptor subunit alpha
ISO
protein:increased expression:nasal mucus, serum
RGD
PMID:12752323
RGD:5128621
NCBI chrNW_004936577:2,776,608...2,797,303
Ensembl chrNW_004936577:2,776,721...2,797,300
G
Il9
interleukin 9
ISO
associated with Bronchial Hyperreactivity
RGD
PMID:15007348
RGD:5128694
NCBI chrNW_004936597:2,983,953...2,986,975
Ensembl chrNW_004936597:2,983,953...2,986,975
G
Itgal
integrin subunit alpha L
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:11593541
RGD:8547687
NCBI chrNW_004936501:12,921,509...12,966,791
Ensembl chrNW_004936501:12,922,642...12,966,663
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
ISO
mRNA:decreased expression:nasal cavity epithelium
RGD
PMID:19158123
RGD:4890001
NCBI chrNW_004936522:3,034,364...3,037,632
Ensembl chrNW_004936522:3,035,346...3,036,350
G
Kdr
kinase insert domain receptor
ISO
protein:increased expression:inferior nasal concha:
RGD
PMID:12515274
RGD:8551781
NCBI chrNW_004936482:17,537,697...17,581,320
Ensembl chrNW_004936482:17,538,864...17,581,002
G
Kitlg
KIT ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15813808
NCBI chrNW_004936507:5,566,144...5,650,412
Ensembl chrNW_004936507:5,565,821...5,650,828
G
Lepr
leptin receptor
ISO
mRNA:increased expression:nose
RGD
PMID:20422702
RGD:5129163
NCBI chrNW_004936591:5,771,371...5,846,177
Ensembl chrNW_004936591:5,774,326...5,836,444
G
LOC101968920
eotaxin
ISO
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:10415058
RGD:4145448
NCBI chrNW_004936538:835,436...848,907
Ensembl chrNW_004936538:835,859...837,710 Ensembl chrNW_004936538:835,859...837,710
G
Met
MET proto-oncogene, receptor tyrosine kinase
ISO
mRNA,protein:increased expression:nasal cavity mucosa:
RGD
PMID:16982975
RGD:8548613
NCBI chrNW_004936589:2,280,803...2,390,179
Ensembl chrNW_004936589:2,280,799...2,390,179
G
Mmp1
matrix metallopeptidase 1
ISO
associated with Rhinosinusitis;mRNA:increased expression:nasal cavity mucosa
RGD
PMID:23064462
RGD:8549735
NCBI chrNW_004936551:5,167,909...5,175,149
Ensembl chrNW_004936551:5,168,044...5,174,857
G
Mmp2
matrix metallopeptidase 2
treatment
ISO
associated with Rhinosinusitis;mRNA:increased expression:nasal cavity mucosa
RGD
PMID:21305560 PMID:23064462
RGD:8549735 RGD:8656001
NCBI chrNW_004936475:7,801,356...7,825,831
Ensembl chrNW_004936475:7,801,277...7,825,851
G
Mmp9
matrix metallopeptidase 9
disease_progression susceptibility
ISO
associated with Asthma, Aspirin-Induced; DNA:polymorphism:promoter: -1562C>T (human) associated with Rhinosinusitis;mRNA:increased expression:nasal cavity mucosa
RGD
PMID:19958602 PMID:23064462 PMID:23987197
RGD:5130861 RGD:8549735 RGD:8657056
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
ISO
RGD
PMID:15715404
RGD:7364740
NCBI chrNW_004936816:129,926...159,396
G
Nos2
nitric oxide synthase 2
ISO
DNA:repeats:promoter mRNA:increased expression:nasal mucosa
RGD
PMID:18714530 PMID:20554417
RGD:4891508 RGD:5509597
NCBI chrNW_004936538:4,052,277...4,097,051
Ensembl chrNW_004936538:4,052,448...4,097,051
G
Nos3
nitric oxide synthase 3
ISO
protein:increased expression:nasal mucosa (human)
RGD
PMID:15942806
RGD:7771559
NCBI chrNW_004936527:6,427,147...6,445,770
Ensembl chrNW_004936527:6,427,093...6,446,534
G
Plaur
plasminogen activator, urokinase receptor
ISO
associated with Sinusitis
RGD
PMID:21711960
RGD:6483796
NCBI chrNW_004936706:840,968...855,552
G
Pon1
paraoxonase 1
ISO
protein:decreased activity:serum (human)
RGD
PMID:23238704
RGD:8547666
NCBI chrNW_004936585:4,954,871...4,979,560
Ensembl chrNW_004936585:4,954,869...4,979,591
G
Ppp1r9b
protein phosphatase 1 regulatory subunit 9B
ISO
associated with Chronic Rhinosinusitis;mRNA:increased expression:mucosa of paranasal sinus (human)
RGD
PMID:18391768
RGD:9999402
NCBI chrNW_004936490:11,497,389...11,514,191
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
associated with Cystic Fibrosis; protein:increased expression:nasal mucosa:
RGD
PMID:16517580
RGD:5143924
NCBI chrNW_004936487:10,745,465...10,758,812
Ensembl chrNW_004936487:10,745,327...10,758,823
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
associated with Cystic Fibrosis; protein:increased expression:nasal mucosa:
RGD
PMID:16517580
RGD:5143924
NCBI chrNW_004936481:3,821,564...3,828,086
G
Sod1
superoxide dismutase 1
ISO
associated with Rhinosinusitis;protein:decreased expression:nasal mucosa: mRNA, protein:increased expression:middle nasal turbinate, lamella (human)
RGD
PMID:16540901 PMID:23921602
RGD:1581230 RGD:8547534
NCBI chrNW_004936500:10,345,154...10,352,873
Ensembl chrNW_004936500:10,345,154...10,352,867
G
Sod2
superoxide dismutase 2
ISO
associated with Rhinosinusitis;mRNA,protein:decreased expression:nasal mucosa:
RGD
PMID:23921602
RGD:8547534
NCBI chrNW_004936489:11,178,338...11,191,601
Ensembl chrNW_004936489:11,178,015...11,191,781
G
Stat3
signal transducer and activator of transcription 3
ISO
RGD
PMID:22959364
RGD:8694314
NCBI chrNW_004936490:17,119,189...17,178,402
Ensembl chrNW_004936490:17,117,290...17,178,402
G
Tgfb1
transforming growth factor beta 1
ISO
mRNA:decreased expression:nasal cavity epithelium associated with Rhinitis
RGD
PMID:12761968 PMID:18423831 PMID:23406597
RGD:4145277 RGD:7394830 RGD:7394852
NCBI chrNW_004936661:3,742,080...3,758,266
Ensembl chrNW_004936661:3,742,066...3,758,272
G
Tlr2
toll like receptor 2
ISO
associated with Cystic Fibrosis;mRNA:increased expression:inferior nasal concha:
RGD
PMID:15836755
RGD:8552992
NCBI chrNW_004936576:522,234...531,660
Ensembl chrNW_004936576:527,434...529,788
G
Tlr4
toll like receptor 4
ISO
associated with Rhinosinusitis;mRNA,protein:increased expression:
RGD
PMID:23157229
RGD:7800741
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
G
Tlr7
toll like receptor 7
ISO
associated with Rhinosinusitis;mRNA,protein:increased expression:
RGD
PMID:23157229
RGD:7800741
NCBI chrNW_004936470:2,593,544...2,610,972
Ensembl chrNW_004936470:2,607,508...2,610,675
G
Tnc
tenascin C
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:12916355
RGD:4889591
NCBI chrNW_004936487:4,172,263...4,256,780
Ensembl chrNW_004936487:4,172,886...4,233,126
G
Tnf
tumor necrosis factor
ISO
DNA:SNPs:promoter:
RGD
PMID:17638785
RGD:4142855
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO
mRNA:decreased expression:nasal polyp (human)
RGD
PMID:19095579
RGD:5131442
NCBI chrNW_004936709:1,407,327...1,421,448
Ensembl chrNW_004936709:1,407,278...1,421,921
G
Tnfrsf1b
TNF receptor superfamily member 1B
ISO
mRNA:decreased expression:nasal polyp (human)
RGD
PMID:19095579
RGD:5131442
NCBI chrNW_004936474:908,414...935,765
Ensembl chrNW_004936474:908,485...934,177
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:Turbinates:
RGD
PMID:12761968
RGD:7394830
NCBI chrNW_004936476:16,245,134...16,261,180
Ensembl chrNW_004936476:16,247,100...16,260,673
G
Abcb1
ATP binding cassette subfamily B member 1
severity
ISO
Nasal Type;protein:increased expression:nasal cavity (human)
RGD
PMID:18756548
RGD:8657087
NCBI chrNW_004936763:1,225,355...1,308,257
Ensembl chrNW_004936763:1,226,482...1,297,427
G
Cd274
CD274 molecule
disease_progression
ISO
associated with Epstein-Barr Virus Infections
RGD
PMID:27595782
RGD:41412182
NCBI chrNW_004936539:132,870...145,288
Ensembl chrNW_004936539:132,868...143,602
G
Cflar
CASP8 and FADD like apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15924153
NCBI chrNW_004936726:381,888...425,565
Ensembl chrNW_004936726:381,835...423,311
G
Fas
Fas cell surface death receptor
ISO
DNA:insertion, deletions:cds:multiple (human)
RGD
PMID:12466128
RGD:8662407
NCBI chrNW_004936735:209,369...234,582
G
Gpx3
glutathione peroxidase 3
treatment
ISO
associated with ethmoid sinus cancer and Neoplasm Metastasis
RGD
PMID:29496492
RGD:151708712
NCBI chrNW_004936647:3,904,787...3,914,223
Ensembl chrNW_004936647:3,906,113...3,913,498
G
Jak3
Janus kinase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22705984 PMID:23689514
NCBI chrNW_004936596:3,212,593...3,224,426
Ensembl chrNW_004936596:3,212,593...3,224,048
G
LOC101954516
signal transducer and activator of transcription 5B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29200404
NCBI chrNW_004936490:17,022,268...17,043,751
Ensembl chrNW_004936490:17,021,051...17,043,941
G
Prdm1
PR/SET domain 1
disease_progression
ISO
RGD
PMID:24438193
RGD:150530467
NCBI chrNW_004936564:2,594,362...2,690,680
Ensembl chrNW_004936564:2,667,660...2,690,683
G
Stat3
signal transducer and activator of transcription 3
ISO
protein:increased expression:nasal cavity (human)
RGD
PMID:17225522
RGD:153298933
NCBI chrNW_004936490:17,119,189...17,178,402
Ensembl chrNW_004936490:17,117,290...17,178,402
G
LOC101959402
deleted in malignant brain tumors 1 protein
ISO
mRNA, Protein:increased expression
RGD
PMID:12419858
RGD:1599782
NCBI chrNW_004936486:11,377,485...11,545,624
G
Mmp2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16178123
NCBI chrNW_004936475:7,801,356...7,825,831
Ensembl chrNW_004936475:7,801,277...7,825,851
G
Anxa1
annexin A1
ISO
RGD
PMID:20970165
RGD:7421559
NCBI chrNW_004936503:9,124,314...9,142,372
Ensembl chrNW_004936503:9,124,264...9,142,413
G
Anxa2
annexin A2
disease_progression
ISO
RGD
PMID:20970165
RGD:7421559
NCBI chrNW_004936471:21,274,112...21,329,286
Ensembl chrNW_004936471:21,274,027...21,329,503
G
Tp53
tumor protein p53
treatment
ISO
DNA:mutations:cds:
RGD
PMID:22575263 PMID:23369851
RGD:8547763 RGD:8547764
NCBI chrNW_004936595:919,807...935,367
Ensembl chrNW_004936595:919,428...925,425
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
protein:decreased expression:serum
RGD
PMID:19725899
RGD:5686851
NCBI chrNW_004936578:3,168,599...3,179,369
Ensembl chrNW_004936578:3,168,331...3,171,928
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
ISO
protein:increased expression:nasal turbinate
RGD
PMID:19364335
RGD:5147461
NCBI chrNW_004936472:25,477,094...25,502,823
Ensembl chrNW_004936472:25,477,010...25,502,840
G
Cat
catalase
ISO
protein:decreased expression:plasma
RGD
PMID:20493834
RGD:5130771
NCBI chrNW_004936533:3,601,270...3,637,128
Ensembl chrNW_004936533:3,600,955...3,637,422
G
Cd40
CD40 molecule
ISO
RGD
PMID:20226305
RGD:5132269
NCBI chrNW_004936514:6,936,915...6,947,246
Ensembl chrNW_004936514:6,936,572...6,947,280
G
Cd86
CD86 molecule
ISO
protein:increased expression:nasal mucosa, dendritic cell (human)
RGD
PMID:17088138
RGD:4892343
NCBI chrNW_004936536:8,414,491...8,481,712
G
Chia
chitinase acidic
ISO
mRNA, protein:increased expression:turbinate, mucosa (human)
RGD
PMID:20422678
RGD:5037226
NCBI chrNW_004939091:1,194...12,273
Ensembl chrNW_004939091:1,190...12,272
G
Egr1
early growth response 1
ISO
DNA:snp:5' utr:g.-4071A>G rs7729723 (human)
RGD
PMID:19833116
RGD:5131984
NCBI chrNW_004936531:7,625,956...7,629,041
Ensembl chrNW_004936531:7,625,892...7,629,749
G
F2rl1
F2R like trypsin receptor 1
ISO
RGD
PMID:17727088
RGD:4892590
NCBI chrNW_004936549:142,281...153,575
Ensembl chrNW_004936549:141,512...153,602
G
Gstp1
glutathione S-transferase pi 1
susceptibility
ISO
DNA:polymorphism:exon:p.I105V (rs1695) (human)
RGD
PMID:17181111
RGD:4142523
NCBI chrNW_004936599:2,197,681...2,200,642
Ensembl chrNW_004936599:2,197,634...2,201,050
G
Hmox1
heme oxygenase 1
ISO
mRNA, protein:increased expression: nasal mucosa
RGD
PMID:16540907
RGD:4145406
NCBI chrNW_004936492:5,042,353...5,049,216
Ensembl chrNW_004936492:5,042,330...5,049,311
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased expression:lung, endothelium (mouse) protein:increased secretion:nasopharynx (human)
RGD
PMID:19047814 PMID:19968652
RGD:4145464 RGD:4145520
NCBI chrNW_004936659:616,570...627,172
Ensembl chrNW_004936659:616,752...627,174
G
Ifngr1
interferon gamma receptor 1
ISO
DNA: SNP: Leu467Pro
RGD
PMID:12851715
RGD:6480431
NCBI chrNW_004936560:4,519,858...4,545,763
Ensembl chrNW_004936560:4,519,474...4,545,796
G
Il13
interleukin 13
ISO
mRNA, protein:increased expression:nasal mucosa
RGD
PMID:8520776
RGD:4782826
NCBI chrNW_004936647:2,529,933...2,532,503
Ensembl chrNW_004936647:2,530,491...2,532,373
G
Il17a
interleukin 17A
severity
ISO
protein:increased expression:serum
RGD
PMID:19226302
RGD:4889151
NCBI chrNW_004936476:8,621,860...8,625,008
Ensembl chrNW_004936476:8,621,860...8,625,008
G
Il18
interleukin 18
susceptibility
ISO
DNA:SNP:promoter:c. -607A>C (rs1946518) (human)
RGD
PMID:16406079
RGD:4889924
NCBI chrNW_004936612:2,306,963...2,325,086
Ensembl chrNW_004936612:2,306,875...2,325,189
G
Il1a
interleukin 1 alpha
ISO
DNA:polymorphism:exon:c.4845G>T (human)
RGD
PMID:14533660
RGD:4142859
NCBI chrNW_004936783:1,210,715...1,218,315
Ensembl chrNW_004936783:1,210,809...1,218,315
G
Il1r1
interleukin 1 receptor type 1
ISO
RGD
PMID:18637763
RGD:5037238
NCBI chrNW_004936713:808,761...881,070
Ensembl chrNW_004936713:808,659...881,076
G
Il2
interleukin 2
ISO
protein:decreased expression:serum:
RGD
PMID:17608155
RGD:8662959
NCBI chrNW_004936662:1,594,953...1,599,625
Ensembl chrNW_004936662:1,594,953...1,599,625
G
Il5
interleukin 5
ISO
protein: increased levels: sputum
RGD
PMID:22186238
RGD:5687140
NCBI chrNW_004936647:2,647,982...2,651,477
Ensembl chrNW_004936647:2,648,241...2,651,430
G
Mmp2
matrix metallopeptidase 2
ISO
protein:increased expression:nasal mucosa:
RGD
PMID:19786210
RGD:5130872
NCBI chrNW_004936475:7,801,356...7,825,831
Ensembl chrNW_004936475:7,801,277...7,825,851
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased expression:nasal mucosa:
RGD
PMID:19786210
RGD:5130872
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
G
Nos2
nitric oxide synthase 2
ISO
protein:increased expression:nasal mucosa
RGD
PMID:14587983
RGD:4892078
NCBI chrNW_004936538:4,052,277...4,097,051
Ensembl chrNW_004936538:4,052,448...4,097,051
G
Nos3
nitric oxide synthase 3
ISO
DNA:snp:promoter:g.-786T>C (human)
RGD
PMID:18086269
RGD:4892054
NCBI chrNW_004936527:6,427,147...6,445,770
Ensembl chrNW_004936527:6,427,093...6,446,534
G
Nr3c1
nuclear receptor subfamily 3 group C member 1
ISO
protein:altered expression:nasal mucosa
RGD
PMID:20185258
RGD:4892593
NCBI chrNW_004936504:10,960,069...11,056,834
Ensembl chrNW_004936504:10,959,192...11,056,856
G
Pparg
peroxisome proliferator activated receptor gamma
ISO
mRNA, protein:increased expression:nasal mucosa (human)
RGD
PMID:17116814
RGD:8552811
NCBI chrNW_004936602:1,230,907...1,368,588
Ensembl chrNW_004936602:1,230,907...1,304,743
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:respiratory system epithelium
RGD
PMID:19364335
RGD:5147461
NCBI chrNW_004936487:10,745,465...10,758,812
Ensembl chrNW_004936487:10,745,327...10,758,823
G
Tbxa2r
thromboxane A2 receptor
treatment
ISO
RGD
PMID:15247523
RGD:11059532
NCBI chrNW_004936588:2,040,712...2,044,635
Ensembl chrNW_004936588:2,040,630...2,045,110
G
Adam33
ADAM metallopeptidase domain 33
susceptibility
ISO
DNA:SNPs: :multiple (human)
RGD
PMID:15298558 PMID:18778489
RGD:4145378 RGD:4145383
NCBI chrNW_004936485:15,005,329...15,018,063
Ensembl chrNW_004936485:15,007,485...15,017,497
G
Ang
angiogenin
ISO
protein:increased expression:sputum
RGD
PMID:19178538
RGD:6892723
NCBI chrNW_004936880:39,372...40,070
G
Bdkrb1
bradykinin receptor B1
ISO
RGD
PMID:12165532
RGD:5129220
NCBI chrNW_004936604:551,774...567,014
G
Bdkrb2
bradykinin receptor B2
ISO
RGD
PMID:1890650 PMID:11149999
RGD:4891033 RGD:4891044
NCBI chrNW_004936604:548,844...551,031
Ensembl chrNW_004936604:548,847...549,956
G
Bdnf
brain derived neurotrophic factor
susceptibility
ISO
DNA:SNP,haplotypes: :rs10767664,rs12273539,rs962369(human) mRNA:increased expression:nasal cavity epithelium
RGD
PMID:20464992 PMID:21723144
RGD:4891116 RGD:8655967
NCBI chrNW_004936540:5,530,081...5,582,765
Ensembl chrNW_004936540:5,529,942...5,585,014
G
C3
complement C3
ISO
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:17345707 PMID:20109314
RGD:5129524 RGD:5129539
NCBI chrNW_004936588:3,985,732...4,023,221
G
C3ar1
complement C3a receptor 1
severity
ISO
protein:increased expression:nasal cavity
RGD
PMID:18538384
RGD:5129559
NCBI chrNW_004936892:347,547...355,143
Ensembl chrNW_004936892:347,842...349,296
G
C5ar1
complement C5a receptor 1
ISO
RGD
PMID:18538384
RGD:5129559
NCBI chrNW_004936664:1,026,216...1,033,438
Ensembl chrNW_004936664:1,032,304...1,033,374
G
Cat
catalase
treatment
ISO
protein:increased activity:blood,nasal cavity mucosa:
RGD
PMID:21541033
RGD:9479054
NCBI chrNW_004936533:3,601,270...3,637,128
Ensembl chrNW_004936533:3,600,955...3,637,422
G
Ccl1
C-C motif chemokine ligand 1
ISO
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:17982926
RGD:4145109
NCBI chrNW_004936538:781,687...784,199
Ensembl chrNW_004936538:781,687...784,199
G
Ccl17
C-C motif chemokine ligand 17
ISO
protein:increased expression:blood, mononuclear cell
RGD
PMID:17517104
RGD:4145498
NCBI chrNW_004936475:9,475,013...9,476,326
Ensembl chrNW_004936475:9,474,961...9,476,398
G
Ccl19
C-C motif chemokine ligand 19
ISO
RGD
PMID:17947663
RGD:5130909
NCBI chrNW_004936524:2,765,271...2,767,259
Ensembl chrNW_004936524:2,765,267...2,767,385
G
Ccl22
C-C motif chemokine ligand 22
ISO
protein:increased expression:blood, mononuclear cell
RGD
PMID:17517104
RGD:4145498
NCBI chrNW_004936475:9,432,505...9,436,240
Ensembl chrNW_004936475:9,432,505...9,436,240
G
Ccl24
C-C motif chemokine ligand 24
ISO
mRNA:increased expression:nasal cavity epithelium DNA:SNPs: :179T>C, 275C>T (human)
RGD
PMID:15580493 PMID:17982926
RGD:4145109 RGD:4891493
NCBI chrNW_004936543:2,400,743...2,403,558
Ensembl chrNW_004936543:2,400,768...2,403,217
G
Ccl26
C-C motif chemokine ligand 26
ISO
DNA:polymorphism: :2497T>G (human) associated with Eosinophilia;protein:increased expression:oronasal secretion (human)
RGD
PMID:15580493 PMID:24989688
RGD:11531119 RGD:4891493
NCBI chrNW_004936543:2,414,948...2,416,922
Ensembl chrNW_004936543:2,414,850...2,416,953
G
Ccl8
C-C motif chemokine ligand 8
ISO
RGD
PMID:20625511
RGD:5131089
NCBI chrNW_004936538:805,273...806,715
Ensembl chrNW_004936538:805,259...806,695
G
Ccr3
C-C motif chemokine receptor 3
ISO
mRNA:increased expression:nose DNA:SNP:exon:51T>C (human) protein:increased expression:blood, T cell
RGD
PMID:17135764 PMID:17156343 PMID:20696593
RGD:4145111 RGD:4145454 RGD:4145645
NCBI chrNW_004936596:223,660...224,739
Ensembl chrNW_004936596:223,660...224,739
G
Cd14
CD14 molecule
resistance susceptibility
ISO
DNA:polymorphism:promoter:c. -159c>T (human)
RGD
PMID:16950285 PMID:20109306
RGD:4144795 RGD:4144810
NCBI chrNW_004936531:9,572,392...9,575,771
Ensembl chrNW_004936531:9,571,796...9,575,923
G
Cd28
CD28 molecule
ISO
RGD
PMID:21356099
RGD:5131612
NCBI chrNW_004936631:335,411...363,407
Ensembl chrNW_004936631:335,411...363,407
G
Cd80
CD80 molecule
ISO
RGD
PMID:21108691
RGD:5132622
NCBI chrNW_004936536:6,462,080...6,483,450
G
Cdc42
cell division cycle 42
ISO
mRNA:increased expression:nasal turbinate
RGD
PMID:19432938
RGD:5688273
NCBI chrNW_004936474:7,556,765...7,598,687
G
Cftr
CF transmembrane conductance regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16083808
NCBI chrNW_004936589:1,565,933...1,719,208
G
Crhr1
corticotropin releasing hormone receptor 1
ISO
mRNA, protein:increased expression:nasal cavity epithelium
RGD
PMID:17597629
RGD:5130940
NCBI chrNW_004936541:2,288,847...2,333,129
Ensembl chrNW_004936541:2,288,841...2,331,689
G
Crhr2
corticotropin releasing hormone receptor 2
ISO
mRNA, protein:increased expression:nasal cavity epithelium
RGD
PMID:17597629
RGD:5130940
NCBI chrNW_004936478:6,901,098...6,947,719
Ensembl chrNW_004936478:6,899,017...6,947,790
G
Ctla4
cytotoxic T-lymphocyte associated protein 4
ISO
protein:increased expression:T cell
RGD
PMID:17625281
RGD:4891512
NCBI chrNW_004936631:484,356...489,643
Ensembl chrNW_004936631:484,356...489,643
G
Cx3cl1
C-X3-C motif chemokine ligand 1
ISO
protein:increased expression:plasma
RGD
PMID:14657873
RGD:4891906
NCBI chrNW_004936475:9,443,851...9,454,715
Ensembl chrNW_004936475:9,443,733...9,455,062
G
Cysltr1
cysteinyl leukotriene receptor 1
ISO
associated with Sinusitis;mRNA:increased expression:nasal cavity epithelium
RGD
PMID:15379985 PMID:16689996 PMID:17627772 PMID:18946234
RGD:4781451 RGD:4783198 RGD:4847512 RGD:4888516
NCBI chrNW_004936547:479,261...504,757
G
Cysltr2
cysteinyl leukotriene receptor 2
ISO
associated with Sinusitis;mRNA:increased expression:nasal cavity epithelium
RGD
PMID:16689996
RGD:4783198
NCBI chrNW_004936565:1,917,970...1,919,027
G
Fcer1a
Fc fragment of IgE receptor Ia
ISO
RGD
PMID:20650300
RGD:5128714
NCBI chrNW_004936740:1,201,370...1,206,871
G
Fis1
fission, mitochondrial 1
ISO
mRNA, protein:increased expression:nasal cavity mucosa (rat)
RGD
PMID:28146064
RGD:13204839
NCBI chrNW_004936543:1,112,746...1,116,521
Ensembl chrNW_004936543:1,112,742...1,116,518
G
Hdc
histidine decarboxylase
ISO
DNA:SNP: :p.E644D (rs2073440) (human)
RGD
PMID:15054596 PMID:20608921
RGD:5128884 RGD:5143921
NCBI chrNW_004936471:12,303,802...12,324,613
Ensembl chrNW_004936471:12,304,130...12,324,570
G
Hnmt
histamine N-methyltransferase
no_association
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17651147
RGD:5128885
NCBI chrNW_004936469:38,125,877...38,166,429
Ensembl chrNW_004936469:38,122,454...38,166,398
G
Hrh1
histamine receptor H1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12167471
NCBI chrNW_004936602:2,182,053...2,185,297
Ensembl chrNW_004936602:2,183,831...2,185,297
G
Il13
interleukin 13
susceptibility disease_progression
ISO
DNA:polymorphism: :rs1800925 (human) associated with asthma; DNA:polymorphisms:promoter:c. -1510A>C, -1055C>T (human) mRNA:increased expression:nose
RGD
PMID:16120094 PMID:17088137 PMID:20358028 PMID:20484924 PMID:20696593
RGD:4145454 RGD:4145534 RGD:4145767 RGD:4159171 RGD:4206706
NCBI chrNW_004936647:2,529,933...2,532,503
Ensembl chrNW_004936647:2,530,491...2,532,373
G
Il13ra2
interleukin 13 receptor subunit alpha 2
ISO
RGD
PMID:17088137
RGD:4159171
NCBI chrNW_004936499:860,179...883,884
Ensembl chrNW_004936499:863,599...883,855
G
Il15
interleukin 15
ISO
RGD
PMID:16750998
RGD:5000756
NCBI chrNW_004936535:6,344,348...6,358,803
Ensembl chrNW_004936535:6,344,395...6,350,197
G
Il16
interleukin 16
ISO
protein:increased expression:nasal cavity epithelium, serum protein:increased expression:serum
RGD
PMID:18254318 PMID:19295235
RGD:5024931 RGD:5024932
NCBI chrNW_004936483:19,417,580...19,512,654
Ensembl chrNW_004936483:19,418,086...19,512,639
G
Il17a
interleukin 17A
ISO
protein:increased expression:nasal mucosa
RGD
PMID:19927541 PMID:20506642
RGD:4889137 RGD:4889144
NCBI chrNW_004936476:8,621,860...8,625,008
Ensembl chrNW_004936476:8,621,860...8,625,008
G
Il18
interleukin 18
disease_progression
ISO
protein:increased expression:serum protein:increased expression:nasal lavage fluid, bronchoalveolar lavage fluid rhinitis allergic, seasonal; protein:increased expression:plasma
RGD
PMID:15934281 PMID:17305282 PMID:17323858
RGD:4889916 RGD:4889917 RGD:4889927
NCBI chrNW_004936612:2,306,963...2,325,086
Ensembl chrNW_004936612:2,306,875...2,325,189
G
Il1b
interleukin 1 beta
susceptibility
ISO
associated with Hypersensitivity;protein:increased expression:nasal mucus mRNA:increased expression:nasal cavity epithelium associated with Hypersensitivity;DNA:polymorphism: :-511C>T (human)
RGD
PMID:10224452 PMID:14533660 PMID:20490816
RGD:4142821 RGD:4142859 RGD:4143227
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
G
Il1rl1
interleukin 1 receptor like 1
severity
ISO
associated with Sinusitis;DNA:SNPs: :multiple (human)
RGD
PMID:19671251
RGD:5144228
NCBI chrNW_004936713:1,020,969...1,035,012
Ensembl chrNW_004936713:1,021,044...1,035,039
G
Il1rn
interleukin 1 receptor antagonist
susceptibility
ISO
associated with Hypersensitivity;DNA:repeat:intron (human)
RGD
PMID:10224452 PMID:14533660 PMID:15178892
RGD:4142859 RGD:4143215 RGD:4143227
NCBI chrNW_004936783:1,447,158...1,466,331
Ensembl chrNW_004936783:1,447,106...1,466,340
G
Il2
interleukin 2
susceptibility
ISO
DNA:SNP:promoter:rs2069762(human)
RGD
PMID:16333313
RGD:8663473
NCBI chrNW_004936662:1,594,953...1,599,625
Ensembl chrNW_004936662:1,594,953...1,599,625
G
Il21
interleukin 21
ISO
RGD
PMID:17982108
RGD:5147397
NCBI chrNW_004936662:1,689,879...1,696,883
Ensembl chrNW_004936662:1,689,879...1,696,883
G
Il22
interleukin 22
severity
ISO
mRNA:increased expression:blood, mononuclear cell
RGD
PMID:21535180
RGD:5147409
NCBI chrNW_004936545:6,227,118...6,231,745
Ensembl chrNW_004936545:6,227,118...6,231,745
G
Il23r
interleukin 23 receptor
susceptibility
ISO
DNA:SNP,haplotype: :rs7517847(human)
RGD
PMID:23696856
RGD:8549605
NCBI chrNW_004936591:4,365,598...4,425,053
Ensembl chrNW_004936591:4,365,762...4,425,005
G
Il27ra
interleukin 27 receptor subunit alpha
ISO
RGD
PMID:19354069
RGD:5128480
NCBI chrNW_004936659:2,706,037...2,720,486
Ensembl chrNW_004936659:2,705,985...2,722,748
G
Il4r
interleukin 4 receptor
ISO
DNA:polymorphism: :c.1432T>C (human)
RGD
PMID:15564773
RGD:4890394
NCBI chrNW_004936501:11,025,590...11,058,807
Ensembl chrNW_004936501:11,025,567...11,058,818
G
Il5
interleukin 5
ISO
RGD
PMID:11884474
RGD:5128622
NCBI chrNW_004936647:2,647,982...2,651,477
Ensembl chrNW_004936647:2,648,241...2,651,430
G
Il9
interleukin 9
ISO
RGD
PMID:20525149
RGD:5128687
NCBI chrNW_004936597:2,983,953...2,986,975
Ensembl chrNW_004936597:2,983,953...2,986,975
G
Lep
leptin
ISO
RGD
PMID:19860581
RGD:5128850
NCBI chrNW_004936479:15,394,966...15,411,334
Ensembl chrNW_004936479:15,394,966...15,411,334
G
LOC101961588
cytochrome P450 2D17
ISO
DNA:SNP:3' utr:*1934G>A (human)
RGD
PMID:20088379
RGD:5143945
NCBI chrNW_004936718:153,340...157,966
G
LOC101968920
eotaxin
severity
ISO
protein:increased expression:nasal mucus associated with Sinusitis;protein:increased expression:paranasal sinus mRNA:increased expression:lung, nose
RGD
PMID:16120080 PMID:16765544 PMID:17999785
RGD:4145411 RGD:4145455 RGD:4145462
NCBI chrNW_004936538:835,436...848,907
Ensembl chrNW_004936538:835,859...837,710 Ensembl chrNW_004936538:835,859...837,710
G
Mfn1
mitofusin 1
ISO
mRNA, protein:increased expression:nasal cavity mucosa (rat)
RGD
PMID:28146064
RGD:13204839
NCBI chrNW_004936566:3,737,315...3,775,894
Ensembl chrNW_004936566:3,737,315...3,775,693
G
Mif
macrophage migration inhibitory factor
severity
ISO
protein:increased expression:serum, nasal mucosa
RGD
PMID:15053202 PMID:15922619
RGD:4891045 RGD:4891056
NCBI chrNW_004936619:1,207,058...1,208,010
Ensembl chrNW_004936619:1,203,746...1,208,442
G
Ms4a2
membrane spanning 4-domains A2
ISO
RGD
PMID:15480314
RGD:5131152
NCBI chrNW_004936581:2,743,133...2,751,925
Ensembl chrNW_004936581:2,744,881...2,751,925
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
ISO
mRNA:increased expression:nose
RGD
PMID:15715404 PMID:20696593
RGD:4145454 RGD:7364740
NCBI chrNW_004936816:129,926...159,396
G
Ngf
nerve growth factor
ISO
associated with Sinusitis;protein:increased expression:respiratory system mucosa protein:increased expression:respiratory system fluid/secretion
RGD
PMID:10224365 PMID:19958603
RGD:4891064 RGD:4891115
NCBI chrNW_004936627:635,784...641,290
Ensembl chrNW_004936627:635,788...645,364
G
Ngfr
nerve growth factor receptor
ISO
protein:increased expression:blood, eosinophil
RGD
PMID:18647313
RGD:5144116
NCBI chrNW_004936490:12,038,500...12,057,257
Ensembl chrNW_004936490:12,035,769...12,057,263
G
Nod1
nucleotide binding oligomerization domain containing 1
ISO
mRNA:decreased expression:nose
RGD
PMID:20384614
RGD:5131446
NCBI chrNW_004936478:6,717,354...6,768,293
Ensembl chrNW_004936478:6,715,245...6,768,372
G
Nod2
nucleotide binding oligomerization domain containing 2
susceptibility
ISO
DNA:polymorphisms:cds:2104C>T,2722G>C (human)
RGD
PMID:12704363
RGD:5131484
NCBI chrNW_004936475:3,708,069...3,742,845
Ensembl chrNW_004936475:3,713,362...3,745,982
G
Nos2
nitric oxide synthase 2
ISO
protein:increased expression:nasal mucosa
RGD
PMID:18254476
RGD:4891910
NCBI chrNW_004936538:4,052,277...4,097,051
Ensembl chrNW_004936538:4,052,448...4,097,051
G
Npy
neuropeptide Y
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12746121
NCBI chrNW_004936478:1,289,437...1,296,819
Ensembl chrNW_004936478:1,290,505...1,296,874
G
Ntrk1
neurotrophic receptor tyrosine kinase 1
ISO
protein:increased expression:eosinophil
RGD
PMID:18647313
RGD:5144116
NCBI chrNW_004936580:6,002,168...6,021,690
Ensembl chrNW_004936580:6,002,120...6,021,709
G
Opa1
OPA1 mitochondrial dynamin like GTPase
ISO
mRNA, protein:increased expression:nasal cavity mucosa (rat)
RGD
PMID:28146064
RGD:13204839
NCBI chrNW_004936711:1,027,531...1,113,796
Ensembl chrNW_004936711:1,032,935...1,106,847
G
Plau
plasminogen activator, urokinase
ISO
mRNA:increased expression:nasal cavity epithelium
RGD
PMID:21339035
RGD:8547809
NCBI chrNW_004936521:5,238,128...5,243,829
Ensembl chrNW_004936521:5,238,093...5,243,877
G
Ptgdr2
prostaglandin D2 receptor 2
ISO
RGD
PMID:19230460 PMID:19608418
RGD:5135017 RGD:5135021
NCBI chrNW_004936581:2,069,355...2,072,535
Ensembl chrNW_004936581:2,067,546...2,070,893
G
Scgb3a2
secretoglobin family 3A member 2
ISO
protein:increased expression:sputum mRNA,protein:decreased expression:nasal mucosa
RGD
PMID:17218572 PMID:21385388
RGD:5144232 RGD:5147389
NCBI chrNW_004936504:6,933,641...6,936,838
Ensembl chrNW_004936504:6,933,769...6,936,838
G
Serpine1
serpin family E member 1
susceptibility
ISO
DNA:polymorphism:promoter:rs1799768 (human)
RGD
PMID:19063817
RGD:4144832
NCBI chrNW_004936543:1,032,543...1,040,956
Ensembl chrNW_004936543:1,032,794...1,039,123
G
Sftpd
surfactant protein D
susceptibility
ISO
associated with Hypersensitivity;DNA:polymorphism: :p.M11T (human)
RGD
PMID:19493231
RGD:4143494
NCBI chrNW_004936716:60,754...73,010
Ensembl chrNW_004936716:60,656...73,099
G
Tap1
transporter 1, ATP binding cassette subfamily B member
susceptibility no_association
ISO
DNA:SNPs: :
RGD
PMID:12018331 PMID:17982230
RGD:6482262 RGD:6482274
NCBI chrNW_004936476:25,899,514...25,907,690
Ensembl chrNW_004936476:25,899,339...25,907,695
G
Tbxa2r
thromboxane A2 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12167471
NCBI chrNW_004936588:2,040,712...2,044,635
Ensembl chrNW_004936588:2,040,630...2,045,110
G
Tgfb1
transforming growth factor beta 1
ISO
associated with Sinusitis
RGD
PMID:18423831
RGD:4145277
NCBI chrNW_004936661:3,742,080...3,758,266
Ensembl chrNW_004936661:3,742,066...3,758,272
G
Tlr2
toll like receptor 2
no_association susceptibility
ISO
associated with Sinusitis;DNA:SNPs: :multiple (human) DNA:SNPs: :597T>C, 1350T>C (human) mRNA:decreased expression:nasal mucosa:
RGD
PMID:18219831 PMID:19128592 PMID:19763595
RGD:4145354 RGD:4145356 RGD:7800742
NCBI chrNW_004936576:522,234...531,660
Ensembl chrNW_004936576:527,434...529,788
G
Tlr6
toll like receptor 6
ISO
associated with Asthma;DNA:SNP: :rs2381289 (human)
RGD
PMID:20815312
RGD:4145352
NCBI chrNW_004936482:6,607,723...6,610,161
Ensembl chrNW_004936482:6,607,753...6,610,143
G
Tnf
tumor necrosis factor
ISO
mRNA:increased expression:nose
RGD
PMID:15120189 PMID:20696593
RGD:4143470 RGD:4145454
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
G
Vegfa
vascular endothelial growth factor A
ISO
protein:increased expression:sputum
RGD
PMID:19178538
RGD:6892723
NCBI chrNW_004936476:16,245,134...16,261,180
Ensembl chrNW_004936476:16,247,100...16,260,673
G
Vip
vasoactive intestinal peptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12746121 PMID:14680090
NCBI chrNW_004936489:5,425,778...5,434,483
Ensembl chrNW_004936489:5,425,726...5,434,785
G
Anxa1
annexin A1
ISO
associated with Nasal Polyps
RGD
PMID:22279949
RGD:7421555
NCBI chrNW_004936503:9,124,314...9,142,372
Ensembl chrNW_004936503:9,124,264...9,142,413
G
C3
complement C3
ISO
protein:increased expression:serum
RGD
PMID:19593977
RGD:4889484
NCBI chrNW_004936588:3,985,732...4,023,221
G
Ccl20
C-C motif chemokine ligand 20
ISO
RGD
PMID:16702571
RGD:7483585
NCBI chrNW_004936525:8,238,128...8,240,974
Ensembl chrNW_004936525:8,237,831...8,240,974
G
Hgf
hepatocyte growth factor
susceptibility
ISO
DNA:haplotype::rs38850,rs38855,rs38857(human)
RGD
PMID:20416453
RGD:8548615
NCBI chrNW_004936734:354,798...428,356
Ensembl chrNW_004936734:356,115...428,779
G
Igf1
insulin like growth factor 1
ISO
mRNA:increased expression:nose:
RGD
PMID:20713758
RGD:8548883
NCBI chrNW_004936492:11,709,623...11,784,028
Ensembl chrNW_004936492:11,709,222...11,778,351
G
Il10
interleukin 10
ISO
protein:decreased expression:blood, mononuclear cell
RGD
PMID:23168151
RGD:7364820
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
G
Il17a
interleukin 17A
ISO
associated with Asthma;mRNA, protein:increased expression:nasal polyps (human)
RGD
PMID:19672092
RGD:4889146
NCBI chrNW_004936476:8,621,860...8,625,008
Ensembl chrNW_004936476:8,621,860...8,625,008
G
Il1b
interleukin 1 beta
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:11197112
RGD:7401169
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
G
Il22ra1
interleukin 22 receptor subunit alpha 1
susceptibility
ISO
DNA:SNPs:5' utr, intron: (rs4292900, rs16829225, rs4648936) (human)
RGD
PMID:19393422
RGD:5147411
NCBI chrNW_004936474:9,184,559...9,201,918
Ensembl chrNW_004936474:9,184,559...9,201,918
G
LOC101975827
complement C4-A
disease_progression
ISO
DNA:deletion: :
RGD
PMID:16879240
RGD:5688262
NCBI chrNW_004936727:1,556,204...1,570,084
G
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:23401274
RGD:8547880
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
treatment
ISO
RGD
PMID:19389874 PMID:23131200
RGD:7349403 RGD:7364734
NCBI chrNW_004936816:129,926...159,396
G
Prkra
protein activator of interferon induced protein kinase EIF2AK2
severity
ISO
associated with Nasal Polyps
RGD
PMID:22961479
RGD:7777146
NCBI chrNW_004936509:7,653,192...7,668,925
Ensembl chrNW_004936509:7,653,047...7,668,896
G
Serpine1
serpin family E member 1
ISO
protein:increased expression:nasal mucosa (human)
RGD
PMID:21711960
RGD:6483796
NCBI chrNW_004936543:1,032,543...1,040,956
Ensembl chrNW_004936543:1,032,794...1,039,123
G
Tlr2
toll like receptor 2
susceptibility
ISO
DNA:polymorphisms:: rs3804099,rs3804100(human) mRNA,protein:increased expression:paranasal sinus
RGD
PMID:21493395 PMID:22182736
RGD:7800733 RGD:8552975
NCBI chrNW_004936576:522,234...531,660
Ensembl chrNW_004936576:527,434...529,788
G
Tlr4
toll like receptor 4
ISO
mRNA,protein:increased expression:paranasal sinus
RGD
PMID:22182736
RGD:7800733
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
G
Tnf
tumor necrosis factor
ISO
protein:increased expression:nasal cavity epithelium
RGD
PMID:11197112 PMID:20147558
RGD:7401169 RGD:7401236
NCBI chrNW_004936727:1,936,066...1,937,766
Ensembl chrNW_004936727:1,936,066...1,937,766
G
Alox5
arachidonate 5-lipoxygenase
ISO
RGD
PMID:16677242
RGD:5147463
NCBI chrNW_004936554:7,807,914...7,848,691
Ensembl chrNW_004936554:7,808,355...7,867,931
G
Apoa4
apolipoprotein A4
resistance
ISO
protein:increased expression:blood serum (human)
RGD
PMID:20810159
RGD:5685642
NCBI chrNW_004936542:2,098,683...2,101,127
Ensembl chrNW_004936542:2,098,683...2,101,127
G
Bdnf
brain derived neurotrophic factor
severity
ISO
protein:increased expression:blood, nasal cavity epithelium
RGD
PMID:18266897
RGD:5144117
NCBI chrNW_004936540:5,530,081...5,582,765
Ensembl chrNW_004936540:5,529,942...5,585,014
G
Ccl5
C-C motif chemokine ligand 5
ISO
protein:increased expression:inferior turbinate, epithelium (human)
RGD
PMID:20459697
RGD:4891379
NCBI chrNW_004936490:253,279...259,947
G
Fga
fibrinogen alpha chain
ISO
RGD
PMID:21887273
RGD:5688767
NCBI chrNW_004936576:1,322,406...1,329,743
G
Gsto1
glutathione S-transferase omega 1
ISO
protein:decreased expression;T lymphocyte:
RGD
PMID:21410266
RGD:5491008
NCBI chrNW_004936600:1,932,152...1,943,342
Ensembl chrNW_004936600:1,930,695...1,943,422
G
Icam1
intercellular adhesion molecule 1
ISO
protein:increased secretion:nasopharynx, secretion (human)
RGD
PMID:20128420
RGD:4145459
NCBI chrNW_004936659:616,570...627,172
Ensembl chrNW_004936659:616,752...627,174
G
Ifngr1
interferon gamma receptor 1
ISO
DNA: SNP: Leu467Pro
RGD
PMID:12851715
RGD:6480431
NCBI chrNW_004936560:4,519,858...4,545,763
Ensembl chrNW_004936560:4,519,474...4,545,796
G
Il10
interleukin 10
treatment
ISO
RGD
PMID:19505388
RGD:7365025
NCBI chrNW_004936557:5,834,874...5,838,502
Ensembl chrNW_004936557:5,834,874...5,838,502
G
Il18
interleukin 18
susceptibility no_association
ISO
DNA:SNPs:promoters, exon:multiple DNA:SNPs:promoters:multiple
RGD
PMID:12532106
RGD:8655871
NCBI chrNW_004936612:2,306,963...2,325,086
Ensembl chrNW_004936612:2,306,875...2,325,189
G
Kdr
kinase insert domain receptor
ISO
protein:increased expression:nasal cavity of mucosa:
RGD
PMID:17651148
RGD:8551771
NCBI chrNW_004936482:17,537,697...17,581,320
Ensembl chrNW_004936482:17,538,864...17,581,002
G
Mc1r
melanocortin 1 receptor
no_association
ISO
RGD
PMID:20357480
RGD:5687317
NCBI chrNW_004936641:193,885...198,730
G
Mmp9
matrix metallopeptidase 9
ISO
DNA:SNPs:promoter, intron, cds:-1590C>T, 2127G>T, p.R668Q (rs3918242, rs2274755, rs17577) (human)
RGD
PMID:22237587
RGD:8547819
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
G
Nod1
nucleotide binding oligomerization domain containing 1
susceptibility
ISO
DNA:SNP: :rs2075817 (human)
RGD
PMID:16918516
RGD:5131519
NCBI chrNW_004936478:6,717,354...6,768,293
Ensembl chrNW_004936478:6,715,245...6,768,372
G
Nod2
nucleotide binding oligomerization domain containing 2
susceptibility
ISO
DNA:polymorphisms:5'UTR/exon, exon:rs5743266, rs2066842 (human)
RGD
PMID:16008671
RGD:5131477
NCBI chrNW_004936475:3,708,069...3,742,845
Ensembl chrNW_004936475:3,713,362...3,745,982
G
Ptgs1
prostaglandin-endoperoxide synthase 1
ISO
protein:increased expression:respiratory system epithelium
RGD
PMID:19364335
RGD:5147461
NCBI chrNW_004936487:10,745,465...10,758,812
Ensembl chrNW_004936487:10,745,327...10,758,823
G
Scgb1a1
secretoglobin family 1A member 1
ISO
mRNA, protein:decreased expression:nasal lavage fluid
RGD
PMID:15836756
RGD:5144234
NCBI chrNW_004936581:798,738...801,614
Ensembl chrNW_004936581:798,739...801,633
G
Tlr3
toll like receptor 3
ISO
protein:decreased expression:bone marrow, blood, eosinophil (human)
RGD
PMID:19752565
RGD:5129130
NCBI chrNW_004936554:3,370,766...3,388,125
Ensembl chrNW_004936554:3,369,469...3,385,907
G
Tlr4
toll like receptor 4
susceptibility
ISO
DNA:polymorphisms:cds:p.D299G, T399I (human)
RGD
PMID:18517079
RGD:4144192
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
G
Vegfa
vascular endothelial growth factor A
ISO
mRNA,protein:increased expression:nasal biopsies,nasal lavage fluid:
RGD
PMID:12633568
RGD:7483595
NCBI chrNW_004936476:16,245,134...16,261,180
Ensembl chrNW_004936476:16,247,100...16,260,673
G
Maml3
mastermind like transcriptional coactivator 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24859338
NCBI chrNW_004936535:7,537,420...7,991,983
Ensembl chrNW_004936535:7,599,660...7,989,952
G
Pax3
paired box 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24859338
NCBI chrNW_004936569:4,215,513...4,307,815
Ensembl chrNW_004936569:4,216,900...4,307,815
G
Smarcb1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
ISO
RGD
PMID:30120966
RGD:127285653
NCBI chrNW_004936619:1,276,239...1,308,945
Ensembl chrNW_004936619:1,275,362...1,308,913
G
Azgp1
alpha-2-glycoprotein 1, zinc-binding
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chrNW_004936543:105,983...113,475
Ensembl chrNW_004936543:105,956...114,190
G
Cfb
complement factor B
ISO
protein:decreased expression:serum
RGD
PMID:14510109
RGD:7411729
NCBI chrNW_004936727:1,595,872...1,602,274
Ensembl chrNW_004936727:1,595,499...1,602,215
G
Cftr
CF transmembrane conductance regulator
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:mutations: :
CTD RGD
PMID:11773581 PMID:16083808
RGD:4140477
NCBI chrNW_004936589:1,565,933...1,719,208
G
Chia
chitinase acidic
severity
ISO
mRNA:decreased expression:sinus, epithelial cell (human)
RGD
PMID:19379605
RGD:5037227
NCBI chrNW_004939091:1,194...12,273
Ensembl chrNW_004939091:1,190...12,272
G
Il13
interleukin 13
susceptibility
ISO
CTD Direct Evidence: marker/mechanism associated with asthma; DNA:polymorphisms:promoter:c. -1510A>C, -1055C>T (human)
CTD RGD
PMID:20358028
RGD:4145767
NCBI chrNW_004936647:2,529,933...2,532,503
Ensembl chrNW_004936647:2,530,491...2,532,373
G
Il1b
interleukin 1 beta
ISO
associated with Hypersensitivity
RGD
PMID:16358839
RGD:4143214
NCBI chrNW_004936783:1,251,678...1,256,807
Ensembl chrNW_004936783:1,252,158...1,257,165
G
Il2
interleukin 2
ISO
RGD
PMID:11758471
RGD:8662964
NCBI chrNW_004936662:1,594,953...1,599,625
Ensembl chrNW_004936662:1,594,953...1,599,625
G
Lta
lymphotoxin alpha
susceptibility
ISO
DNA:polymorphism: :
RGD
PMID:11037831
RGD:4143260
NCBI chrNW_004936727:1,940,081...1,941,022
Ensembl chrNW_004936727:1,940,081...1,941,022
G
Met
MET proto-oncogene, receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chrNW_004936589:2,280,803...2,390,179
Ensembl chrNW_004936589:2,280,799...2,390,179
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased expression: :
RGD
PMID:20392482
RGD:5130763
NCBI chrNW_004936514:7,038,240...7,045,873
Ensembl chrNW_004936514:7,037,639...7,045,793
G
Muc5b
mucin 5B, oligomeric mucus/gel-forming
ISO
protein:increased secretion:sinus mucus
RGD
PMID:17063754
RGD:5131192
NCBI chrNW_004936816:174,943...209,241
G
Nr3c1
nuclear receptor subfamily 3 group C member 1
ISO
RGD
PMID:18396779
RGD:4892328
NCBI chrNW_004936504:10,960,069...11,056,834
Ensembl chrNW_004936504:10,959,192...11,056,856
G
Pdgfb
platelet derived growth factor subunit B
ISO
protein: increased expression: nasal cavity epithelium
RGD
PMID:21255638
RGD:6483060
NCBI chrNW_004936492:2,353,840...2,368,573
Ensembl chrNW_004936492:2,353,841...2,368,573
G
Pip
prolactin induced protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chrNW_004936527:540,051...544,586
Ensembl chrNW_004936527:540,008...544,586
G
Plau
plasminogen activator, urokinase
ISO
RGD
PMID:21711960
RGD:6483796
NCBI chrNW_004936521:5,238,128...5,243,829
Ensembl chrNW_004936521:5,238,093...5,243,877
G
Plaur
plasminogen activator, urokinase receptor
ISO
RGD
PMID:21711960
RGD:6483796
NCBI chrNW_004936706:840,968...855,552
G
Ppp1r9b
protein phosphatase 1 regulatory subunit 9B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18391768
NCBI chrNW_004936490:11,497,389...11,514,191
G
Scgb3a2
secretoglobin family 3A member 2
ISO
mRNA,protein:decreased expression:nasal mucosa
RGD
PMID:21385388
RGD:5147389
NCBI chrNW_004936504:6,933,641...6,936,838
Ensembl chrNW_004936504:6,933,769...6,936,838
G
Sftpd
surfactant protein D
ISO
associated with Cystic Fibrosis;mRNA:increased expression:respiratory system mucosa
RGD
PMID:17599561
RGD:4143506
NCBI chrNW_004936716:60,754...73,010
Ensembl chrNW_004936716:60,656...73,099
G
Tlr2
toll like receptor 2
ISO
mRNA:increased expression:nasal cavity epithelium:
RGD
PMID:14743629
RGD:8552991
NCBI chrNW_004936576:522,234...531,660
Ensembl chrNW_004936576:527,434...529,788
G
Tlr4
toll like receptor 4
ISO
mRNA:increased expression:nasal cavity epithelium: associated with Pneumococal Infections;
RGD
PMID:14743629 PMID:16301373
RGD:7800729 RGD:8552991
NCBI chrNW_004936487:6,519,140...6,532,018
Ensembl chrNW_004936487:6,518,441...6,533,095
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all